Phenotypic differences between human blood monocyte subpopulations in psoriasis and atopic dermatitis

Journal of Dermatology

Volumn 24, Issue 6, 1997, Pages 370-378

  Zheng, Min ^a   Mrowietz, Ulrich ^b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Atopic dermatitis; Monocyte subpopulations; Phenotypes; Psoriasis

Indexed keywords

CD14 ANTIGEN; CD16 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; ATOPIC DERMATITIS; CELL DENSITY; CELL DIFFERENTIATION; CELL MATURATION; CELL SIZE; CELL SUBPOPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHENOTYPE; PSORIASIS;

EID: 0030751575     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1997.tb02807.x     Document Type: Article

References (44)

1. Bata-Csorgo Z, Hammerburg C, Voorhees JJ, Cooper KD: Intralesional T-lymphocyte activation as a mediator of psoriasis epidermal hyperplasia, J Invest Dermatol, 105: 89s-94s, 1995.
2. Cooper KD: Atopic dermatitis: Recent trends in pathogenesis and therapy, J Invest Dermatol, 102: 128-137, 1994.
3. Schlaak JF, Buslau M, Jochum W, et al: T cells involved in psoriasis vulgaris belong to the Th1 subset, J Invest Dermatol, 102: 145-149, 1994.
4. Cooper KD: Atopic dermatitis: Recent trends in pathogenesis and therapy, J Invest Dermatol, 102: 128-137, 1994.
5. Schubert C, Christophers E: Mast cells and macrophages in early relapsing psoriasis, Arch Dermatol Res, 277: 352-358, 1985.
6. Christophers E, Mrowietz U: The inflammatory infiltrate in psoriasis, Clin Dermatol, 13: 131-135, 1995.
7. Meuret G, Schmitt E, Hagedorn M: Monocytopoiesis in chronic eczematous diseases, psoriasis vulgaris and mycosis fungoides, J Invest Dermatol, 66: 22-28, 1976.
8. Neuner P, Urbanski A, Trautinger F, et al: Increased IL-6 production by monocytes and keratinocytes in patients with psoriasis, J Invest Dermatol, 97: 27-33, 1991.
9. Zachary CB, Poulter LW, MacDonald DM: Cell-mediated immune responses in atopic dermatitis: The relevance of antigen-presenting cells, Br J Dermatol, 113: 10-16, 1985.
10. Buckley CC, Ivison C, Poulter LW, Rustin MH: Fc episilon R11/CD23 receptor distribution in patch test reaction to aeroallergens in atopic dermatitis, J Invest Dermatol, 99: 184-188, 1992.
11. Polla BS, Ezekowitz RA, Leung DY: Monocytes from patients with atopic dermatitis are primed for Superoxide production, J Allergy Clin Immunol, 89: 545-551, 1992.
12. Hanifin JM, Chan SC: Monocyte phosphodiesterase abnormalities and deregulation of lymphocyte function in atopic dermatitis, J Invest Dermatol, 105: 84s-88s, 1995.
13. Wüthrich B, Kägi MK, Joller-Jemelka H: Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis, Arch Dermatol Res, 284: 339-342, 1992.
14. Bratton DL, Hamid Q, Boguniewicz M, Doherty DE, Kailey JM, Leung DY: Granulocyte macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis, J Clin Invest, 95: 211-218, 1995.
15. Mason RR, Weiner RS: Application of the Beckman JE-6B Elutriator System in the isolation of human minocyte subpopulations, Scand J Haematol, 34: 5-8, 1985.
16. Inamura N, Sone S, Okubo A, Singh SM, Ogura T: Heterogeneity in responses of human blood monocytes to granulocyte-macrophage colony-stimulating factor, J Leukoc Biol, 47: 528-534, 1990.
17. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis, Acta Derm Benerol (Stockh), 92: 44-47, 1980.
18. Zheng M, Yang H, Mrowietz U: Isolation of human monocyte subpopulations by single-step counterflow centrifugation elutriation using a Sanderson chamber: Phenotypical and functional characterization of isolated cells, Clin Biotechnol, 3: 197-201, 1991.
19. Ziegler-Heitbrock HWL, Ströbel M, Kieper D, et al: Differential expression of cytokines in human blood monocyte subpopulations, Blood, 79: 503-511, 1992.
20. Volk HD, Diezel W, Waschke SR, et al: Abnorme HLA-DR-Antigenexpression an Monozyten von Patienten mit Lupus erythematodes viszeralis und Psoriasis vulgaris, Dermatol Monatsschr, 171: 308-311, 1985.
21. Davies DE, Lloyd JB: Monocyte-to-macrophage transition in vitro. A systematic study using human cells isolated by fractionation on Percoll, J Immunol Methods, 118: 9-16, 1989.
22. Maoz H, Polliack A, Barak V, et al: Parameters affecting the in vitro maturation of human monocytes to macrophages, Int J Cell Cloning, 4: 167-185, 1986.
23. Meuret G: Entstehung und Lebenszyklus des menschlichen Monozyten, Nucl Med, 22: 75-81, 1983.
24. Le J, Vilcek J: Lymphokine-mediated activation of human monocytes: Neutralization by monoclonal antibody to interferon-gamma, Cell Immunol, 85: 278-283, 1984.
25. Breen FN, Hume DA, Weidemann MJ: Interactions among granulocyte-macrophage colony-stimulation factor, macrophage colony-stimulating factor, and IFN-gamma lead to enhanced proliferation of murine macrophage progenitor cells, J Immunol, 147: 1542-1547, 1991.
26. Bonifati C, Carducci M, Cordiali-Fei P, et al: Correlated increases of tumor necrosis factor-alpha, interleukin-6, and granulocyte-macrophage colony stimulating factor levels in suction blister fluids and sera of psoriatic patients - Relationships with disease severity, Clin Exp Dermatol, 19: 383-387, 1994.
27. Jansen JH, Kluin-Nelemans JC, Van-Damme J, Wientjen GJ, Willemze R, Fibbe WE: Interleukin 6 is a permissive factor for monocytic colony formation by human hematopoietic progenitor cells, J Exp Med, 175: 1151-1154, 1992.
28. Livingston DH, Loder PA, Kramer SM, Gibson UE, Polk HCJ: Interferon gamma administration increases monocyte HLA-DR antigen expression but not endogenous interferon production, Arch Surg, 129: 172-178, 1994.
29. Hanifin JM, Schneider LC, Leung DYD, et al: Recombinant interferon gamma therapy for atopic dermatitis, J Am Acad Dermatol, 28: 189-197, 1993.
30. Volk HD, Koyka I, Goan SR, et al: Serum mediated inhibition of the interferon-gamma-induced HLA-DR expression on monocytes in patients with psoriasis, J Invest Dermatol, 87: 524-527, 1986.
31. Dougherty GJ, Murdoch S, Hogg N: The function of human intercellular adhesion molecule-1 (ICAM-1) in the generation of an immune response, Eur J Immunol, 18: 35-39, 1988.
32. Patarroyo N: Adhesion molecules mediating recruitment of monocytes to inflamed tissue, Immunobiology, 191: 474-477, 1994.
33. Goebeler M, Ruth J, Kunz M, Sorg C: Expression of intercellular adhesion molecule-1 by murine macrophages is upregulated during differentiation and inflammatory activation, Immunobiology, 188: 159-171, 1993.
34. Acuto O, Reinherz EL: The human T-cell receptor, N Eng J Med, 312: 1100-1111, 1985.
35. Espinoza DI, Bosco MC, Musso T, Gusella GL, Longo DL, Varesio L: Interleukin-2 and human monocyte activation, J Leukor Biol, 57: 13-19, 1995.
36. Kapp A, Piskorski A, Schöpf E: Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis, Br J Dermatol, 119: 707-710, 1988.
37. Espinoza-Delgado I, Bosco MC, Musso T, Gusella GL, Longo DL, Varesio L: Interleukin-2 and human monocyte activation, J Leukocyte Biol, 57: 13-19, 1995.
38. Holter W, Grunow R, Stockinger H, Knapp W: Recombinant interferon-γ induces interleukin 2 receptors on human peripheral blood monocytes, J Immunol, 136: 2171-2175, 1986.
39. Jujo K, Renz H, Abe J, Gelfand EW, Leung DY: Decreased interferon gamma and increased interleukin-4 production in atopic dermatitis promotes IgE synthesis, J Allergy Clin Immunol, 90: 323-331, 1992.
40. Reinhold U, Wehrmann W, Kukel S, Kreysel HW: Evidence that defective interferon-gamma production in atopic dermatitis patients is due to intrinsic abnormalities, Clin Exp Immunol, 79: 374-379, 1990.
41. Vouldoukis I, Issaly F, Fourcade C, et al: CD23 and IgE expression during the human immune response to cutaneous leishmaniasis: Possible role in monocyte activation. Res Immunol, 145: 17-27, 1994.
42. Eierman D, Johnson C, Haskill S: Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates, J Immunol, 142: 1970-1976, 1989.
43. Haskill S, Johnson C, Eierman D, Becker S, Warren K: Adherence induces selective mRNA expression of monocyte mediators and proto-oncogenes, J Immunol, 140: 1690-1694, 1988.
44. Dransfield I, Corcoran D, Partridge LJ, Hogg N, Burton DR: Comparison of human monocytes isolated by elutriation and adherence suggest that heterogeneity may reflect a continuum of maturation/activation states, Immunol, 63: 491-496, 1988.